Verition Fund Management’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-62,094
Closed -$2.36M 3527
2024
Q4
$2.36M Sell
62,094
-31,195
-33% -$1.6M 0.01% 1438
2024
Q3
$3.12M Sell
93,289
-29,095
-24% -$1.22M 0.02% 1148
2024
Q2
$4.15M Sell
122,384
-17,707
-13% -$978K 0.02% 836
2024
Q1
$12.6M Buy
140,091
+82,005
+141% +$4.48M 0.09% 240
2023
Q4
$2.78M Buy
+58,086
New +$1.91M 0.02% 681
2022
Q4
Sell
-205
Closed -$18K 2456
2022
Q3
$18K Hold
205
﹤0.01% 2798
2022
Q2
$15K Buy
+205
New +$13.9K ﹤0.01% 2239

Other funds holding KRRO

Verition Fund Management's KRRO Position: Q1 2025 in Review

Verition Fund Management sold out of Korro Bio (KRRO) in Q1 2025, closing a stake of 62,094 shares — an estimated $2.36M sold.

Verition Fund Management first reported a position in KRRO in Q2 2022 and held it in 7 quarters. The position peaked at $12.6M in Q1 2024. 75 funds tracked by Wall St. Rank hold KRRO as of Q1 2025.

  • Verition Fund Management reported no remaining Korro Bio position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 62,094 Korro Bio shares in Q1 2025, an estimated $2.36M.
  • Verition Fund Management first reported a position in Korro Bio in Q2 2022 and held it in 7 quarters.
  • Verition Fund Management's Korro Bio position peaked at $12.6M in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Korro Bio as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.